BRTX
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- BioRestorative Therapies reported positive Phase 2 blinded data showing improvement in pain and function with BRTX-100Mar 30, 2026
- BioRestorative completed patient enrollment in a Phase 2 trial of BRTX-100 for chronic lumbar disc diseaseFeb 10, 2026
- BioRestorative awarded notice of allowance for Japanese patent, expanding protection for potential cell-based alternative to multi-billion dollar GLP-1 drug marketOct 27, 2025
- BioRestorative reveals promising early data for BRTX-100, a stem cell therapy for chronic lumbar disc diseaseJun 16, 2025
- BioRestorative to present key update on early promising Phase 2 BRTX-100 results at ISSCR 2025Jun 9, 2025